1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Collaborative Neuroscience Research, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia Xanomeline and Trospium Chloride - Schizophrenia Disorders | Phase 4 | Not yet recruiting | Collaborative Neuroscience Research, LLC | 100 | 2025-04-01 | 2025-04-11 |
Schizophrenia (1)
trospium chloride (1) · xanomeline (1)
United States (1)